Science Explorer Back to mapMap
Discussion
Researcher · Springer Nature (Germany) · Germany

Silke Wedekind

Silke Wedekind publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#7,710,155
of 7,710,434 ranked researchers
Rank in Germany
#364,318
of 364,343
Works
565
Citations
32
Citations per work
0.1
h-index
2
i10-index 1Top 99% in Oncology
Silke Wedekind

What does Silke Wedekind research?

Silke Wedekind's work is mostly in Medicine (43%), Immunology and Microbiology (4%).

Everything else: 295 works · 52.3% of their workHealth Sciences: 244 works · 43.2% of their workMedicine: 244 works · 43.2% of their workOncology: 82 works · 14.6% of their workPulmonary and Respiratory Medicine: 67 works · 11.8% of their workSurgery: 33 works · 5.8% of their workHematology: 32 works · 5.6% of their workGenetics: 31 works · 5.4% of their workLife Sciences: 25 works · 4.5% of their workImmunology and Microbiology: 25 works · 4.5% of their workImmunology: 25 works · 4.5% of their workTHEIR WORKSilke Wedekind565works
Life Sciences4%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else29552.3%
    1. Medicine24443.2%
    1. Immunology and Microbiology254.5%
  1. 1Oncology15% of their works
  2. 2Pulmonary and Respiratory Medicine12% of their works
  3. 3Surgery6% of their works
  4. 4Hematology6% of their works
  5. 5Genetics5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Silke Wedekind's research?

The keywords of their largest research topics: EGFR Mutations, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. EGFR Mutations601 topic
  2. Targeted Therapy601 topic
  3. Immune Checkpoint Blockade541 topic
  4. PD-1 and PD-L1541 topic
  5. BCR-ABL351 topic
  6. Imatinib351 topic
  7. Chronic Lymphocytic Leukemia341 topic
  8. Genomic Aberrations341 topic
  9. Cetuximab291 topic
  10. KRAS Mutations291 topic
  11. CAR T Cells231 topic
  12. Chimeric Antigen Receptor231 topic
  13. Health Surveys231 topic
  14. Public Health231 topic
  15. JAK2 Mutation221 topic
  16. Myelofibrosis221 topic

Where does Silke Wedekind work?

Silke Wedekind's main affiliation in the publication record is Springer Nature (Germany), Germany.

How many publications and citations does Silke Wedekind have?

OpenAlex counts 565 works and 32 citations for Silke Wedekind, an h-index of 2, ranking #7,710,155 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Silke Wedekind. Posts are plain text and can be reported.